Takao Shimizu graduated from the Medical School at the University of Tokyo. After a 2- year clinical training, TS had postdoc experience at Kyoto University (Osamu. Hayaishi) and Karolinska Institutet (Bengt Samuelsson). He became an associate professor at the University of Tokyo in 1984, and full professor of Biochemistry and Molecular Biology in 1991. Served as Dean and Vice President of the University between 2007-2013. Since 2012, he opened a new laboratory of lipid signaling at the National Center for Global Health and Medicine. He has been working on enzymes and receptors of various lipid mediators (PLA2, lipoxygenases, LTA4 hydrolase, receptors for PAF, LTB4 and lysophosphatidic acid (LPA4)). Since 2003, he initiated lipidomics program at the University of Tokyo, and studies extensively glycerophospholipid metabolism and functions in animals. Served Editorial Board for JBC for 18 years, authored >400 papers, and worked for medical researcher training program in Japan. Awarded by Ernst Schering Prize in 2000, Japan Academy Award in 2008, and Outstanding Research Achievement Award from Eicosanoid Research Foundation in 2013. Lifetime achievement Award from PLA2 meeting in 2013.